Sasmita Mishra - Concepedia

Author

Sasmita Mishra

EpiVax (United States)

Also Known As

Sasmita Mishra, Sasmita Mishra (613021)

Publications

349

Citations

H-Index

Concepts

All Affiliations

EpiVax (United States)Rhode Island Hospital Brown University Providence College University of Rhode Island

About

Sasmita Mishra is an author at EpiVax (United States) specializing in immunology, medicine, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	116
2	Immunology	4	4	116
3	Autoimmunity	2	2	64
4	Cell Biology	1	1	21
5	Cancer Cell Biology	1	1	40

Sasmita Mishra

Publications

341

Citations

H-Index

Page 1

	Year	Citations
LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates James W. Purcell, Sonia G. Tanlimco, Jonathan A. Hickson, Cancer Research	2018	189
HCV epitope, homologous to multiple human protein sequences, induces a regulatory T cell response in infected patients Phyllis Losikoff, Sasmita Mishra, Frances Terry, Journal of Hepatology Viral PersistenceMedicineHcv EpitopeHuman RetrovirusImmunology	2014	43
Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma Yoshito Tomimaru, Sasmita Mishra, Howard Safran, Vaccine Liver PhysiologyImmunologyTumor ImmunityCancer Cell BiologyLiver Cancer	2015	40
Clearance of systemic hematologic tumors by venetoclax (Abt‐199) and navitoclax Scott Ackler, Anatol Oleksijew, Jun Chen, Pharmacology Research & Perspectives	2015	26
Peptide-pulsed dendritic cells induce the hepatitis C viral epitope-specific responses of naïve human T cells Sasmita Mishra, Phyllis Losikoff, Alyssa A. Self, Vaccine VaccinationT-regulatory CellImmunologyHepatitisAntigen Processing	2014	21
Dendritic Cell-Mediated, DNA-Based Vaccination against Hepatitis C Induces the Multi-Epitope-Specific Response of Humanized, HLA Transgenic Mice Sasmita Mishra, Bianca J. Lavelle, Joe Desrosiers, PLoS ONE Hepatitis C VirusImmunologyImmunodominanceCd4 T Cell ResponsesImmunotherapeutics	2014	12
Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR Kedar S. Vaidya, Michael J. Mitten, Adelyn L. Zelaya-Lazo, Journal of Neuro-Oncology	2021	10

Page 1